Celinetoh
2021-11-28
ok
@jayc:
$Novavax(NVAX)$I reviewed all GMP and cGMP certificates for the Novavax's global sites. I can fully understand why Novavax leveraged the manufacturing partnership with Serum. This strategy really makes their CMC package harmonized and simplified as Serum's MHRA GMP certificate covers full line-up of the manufacturing operations from DS/DP to QC Testing without requiring any combinations of sites. Serum's MHRA GMP Coverage 1. Manufacturing Operations 2. 1.1 Sterile Products 3. 1.3 Biological medical products 4. 1.4 Other products or manufacturing activity 5. 1.5 Packaging 6. 1.5.1 Primary packaging 7. 1.5.2 Secondary packaging 8. 1.6 Quality control testing If Novavax uses other global sites, they need to combine several sites to manufacture Nuvaxovid from DS to DP (fill & finish). This makes their CMC package complicate to keep consistency each for the regulatory agencies and difficult to get approval quickly. No other single site can cover full line-up of the manufacturing operations except Serum. Novavax made the best choice to get their CMC package optimized. Fantastic strategy !!!!
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":600327749,"tweetId":"600327749","gmtCreate":1638072153881,"gmtModify":1638072154041,"author":{"id":3582191671584736,"idStr":"3582191671584736","authorId":3582191671584736,"authorIdStr":"3582191671584736","name":"Celinetoh","avatar":"https://static.tigerbbs.com/2f7c6c2d8eb6fad9569bcb424b9ecb10","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><u>ok</u></body></html>","htmlText":"<html><head></head><body><u>ok</u></body></html>","text":"ok","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/600327749","repostId":877474069,"repostType":1,"repost":{"magic":2,"id":877474069,"tweetId":"877474069","gmtCreate":1637978130461,"gmtModify":1637997760944,"author":{"id":4090153192826740,"idStr":"4090153192826740","authorId":4090153192826740,"authorIdStr":"4090153192826740","name":"jayc","avatar":"https://static.tigerbbs.com/19c91ee324a75aab3e761bbbe23dc892","vip":2,"userType":2,"introduction":"Think long-term even if you have very little to invest.","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5046,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/591f362ca10282c343bffdaf766f944d","width":"2000","height":"1333"}],"coverImages":[{"img":"https://static.tigerbbs.com/591f362ca10282c343bffdaf766f944d","width":"2000","height":"1333"}],"extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>I reviewed all GMP and cGMP certificates for the Novavax's global sites. I can fully understand why Novavax leveraged the manufacturing partnership with Serum. This strategy really makes their CMC package harmonized and simplified as Serum's MHRA GMP certificate covers full line-up of the manufacturing operations from DS/DP to QC Testing without requiring any combinations of sites.</p><p>Serum's MHRA GMP Coverage</p><p>1. Manufacturing Operations</p><p>2. 1.1 Sterile Products</p><p>3. 1.3 Biological medical products</p><p>4. 1.4 Other products or manufacturing activity</p><p>5. 1.5 Packaging</p><p>6. 1.5.1 Primary packaging</p><p>7. 1.5.2 Secondary packaging</p><p>8. 1.6 Quality control testing If Novavax uses other global sites, they need to combine several sites to manufacture Nuvaxovid from DS to DP (fill & finish). This makes their CMC package complicate to keep consistency each for the regulatory agencies and difficult to get approval quickly. No other single site can cover full line-up of the manufacturing operations except Serum.</p><p>Novavax made the best choice to get their CMC package optimized. Fantastic strategy !!!! </p><p><img src=\"https://static.tigerbbs.com/591f362ca10282c343bffdaf766f944d\" tg-width=\"2000\" tg-height=\"1333\"></p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>I reviewed all GMP and cGMP certificates for the Novavax's global sites. I can fully understand why Novavax leveraged the manufacturing partnership with Serum. This strategy really makes their CMC package harmonized and simplified as Serum's MHRA GMP certificate covers full line-up of the manufacturing operations from DS/DP to QC Testing without requiring any combinations of sites.</p><p>Serum's MHRA GMP Coverage</p><p>1. Manufacturing Operations</p><p>2. 1.1 Sterile Products</p><p>3. 1.3 Biological medical products</p><p>4. 1.4 Other products or manufacturing activity</p><p>5. 1.5 Packaging</p><p>6. 1.5.1 Primary packaging</p><p>7. 1.5.2 Secondary packaging</p><p>8. 1.6 Quality control testing If Novavax uses other global sites, they need to combine several sites to manufacture Nuvaxovid from DS to DP (fill & finish). This makes their CMC package complicate to keep consistency each for the regulatory agencies and difficult to get approval quickly. No other single site can cover full line-up of the manufacturing operations except Serum.</p><p>Novavax made the best choice to get their CMC package optimized. Fantastic strategy !!!! </p><p><img src=\"https://static.tigerbbs.com/591f362ca10282c343bffdaf766f944d\" tg-width=\"2000\" tg-height=\"1333\"></p></body></html>","text":"$Novavax(NVAX)$I reviewed all GMP and cGMP certificates for the Novavax's global sites. I can fully understand why Novavax leveraged the manufacturing partnership with Serum. This strategy really makes their CMC package harmonized and simplified as Serum's MHRA GMP certificate covers full line-up of the manufacturing operations from DS/DP to QC Testing without requiring any combinations of sites. Serum's MHRA GMP Coverage 1. Manufacturing Operations 2. 1.1 Sterile Products 3. 1.3 Biological medical products 4. 1.4 Other products or manufacturing activity 5. 1.5 Packaging 6. 1.5.1 Primary packaging 7. 1.5.2 Secondary packaging 8. 1.6 Quality control testing If Novavax uses other global sites, they need to combine several sites to manufacture Nuvaxovid from DS to DP (fill & finish). This makes their CMC package complicate to keep consistency each for the regulatory agencies and difficult to get approval quickly. No other single site can cover full line-up of the manufacturing operations except Serum. Novavax made the best choice to get their CMC package optimized. Fantastic strategy !!!!","highlighted":2,"essential":2,"paper":1,"link":"https://laohu8.com/post/877474069","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["NVAX"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":937,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":729,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/600327749"}
精彩评论